- Isocorynoxeine
-
- $80.00 / 1mL
-
2024-11-19
- CAS:51014-29-0
- Min. Order:
- Purity: 99.66%
- Supply Ability: 10g
- Isocorynoxeine
-
- $0.00 / 20mg
-
2023-02-24
- CAS:51014-29-0
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- Isocorynoxeine
-
- $1.00 / 1kg
-
2019-07-06
- CAS:51014-29-0
- Min. Order: 1 mg
- Purity: 99%
- Supply Ability: 100KG
|
| | Isocorynoxeine Basic information |
| Product Name: | Isocorynoxeine | | Synonyms: | Isocorynoxeine;(16E,20α)-16,17,18,19-Tetradehydro-17-methoxy-2-oxocorynoxan-16-carboxylic acid methyl ester;(alphaE,1'S,6'R,7'S,8'aS)-6'-ethenyl-1,2,2',3',6',7',8',8'a-octahydro-alpha-(methoxymethylene)-2-oxospiro[3H-indole-3,1'(5'H)-indolizine]-7'-acetic acid methyl ester;Isocorynoxeine, BR;Isocorynoxeine (7-Isocorynoxeine);Spiro[3H-indole-3,1'(5'H)-indolizine]-7'-acetic acid, 6'-ethenyl-1,2,2',3',6',7',8',8'a-octahydro-α-(methoxymethylene)-2-oxo-, methyl ester, (αE,1'S,6'R,7'S,8'aS)-;Isocorynoxeine USP/EP/BP;methyl (E)-2-[(3S,6'R,7'S,8'aS)-6'-ethenyl-2-oxospiro[1H-indole-3,1'-3,5,6,7,8,8a-hexahydro-2H-indolizine]-7'-yl]-3-methoxyprop-2-enoate | | CAS: | 51014-29-0 | | MF: | C22H26N2O4 | | MW: | 382.46 | | EINECS: | | | Product Categories: | chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract | | Mol File: | 51014-29-0.mol |  |
| | Isocorynoxeine Chemical Properties |
| Boiling point | 562.7±50.0 °C(Predicted) | | density | 1.25 | | solubility | DMSO : 50 mg/mL (130.74 mM; Need ultrasonic) | | form | Powder | | pka | 13.54±0.60(Predicted) | | color | White to off-white |
| | Isocorynoxeine Usage And Synthesis |
| Description | The leaves of Mitragyna rotundlfolia grown in Burma have recently been found
to contain this alkaloid. This is the first reported occurrence of the base in
nature. The structure has been established from spectroscopic investigations. | | Uses | 7-Isocorynoxeine is a bioactive oxindole alkaloid in the Uncaria species. Displays wide array of beneficial cardiovascular and cardiocerebral vascular system effects. | | target | 5-HT2A receptor | NO | | References | Houghton, Shellard, Planta Med., 26, 104 (1974) |
| | Isocorynoxeine Preparation Products And Raw materials |
|